Found: 38
Select item for more details and to access through your institution.
Correlation of MYC Gene and Protein Status With Breast Cancer Subtypes and Outcome of Patients Treated With Anthracycline-Based Adjuvant Chemotherapy. Pooled Analysis of 2 Hellenic Cooperative Group Phase III Trials.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Perceptions and experiences of fertility preservation in female patients with cancer in Greece.
- Published in:
- BMC Women's Health, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12905-024-02955-x
- By:
- Publication type:
- Article
A retrospective multicentric cohort study of checkpoint inhibitors‐induced pruritus with focus on management.
- Published in:
- Photodermatology, Photoimmunology & Photomedicine, 2023, v. 39, n. 5, p. 506, doi. 10.1111/phpp.12892
- By:
- Publication type:
- Article
New Agents Targeting Angiogenesis in Glioblastoma.
- Published in:
- Chemotherapy Research & Practice, 2011, p. 1, doi. 10.1155/2011/878912
- By:
- Publication type:
- Article
Real-World Data on Treatment Management and Outcomes of Patients with Newly Diagnosed Advanced Epithelial Ovarian Cancer in Greece (The EpOCa Study).
- Published in:
- Current Oncology, 2021, v. 28, n. 6, p. 5266, doi. 10.3390/curroncol28060440
- By:
- Publication type:
- Article
Significance of PIK3CA Mutations in Patients with Early Breast Cancer Treated with Adjuvant Chemotherapy: A Hellenic Cooperative Oncology Group (HeCOG) Study.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0140293
- By:
- Publication type:
- Article
Differential Expression of the Insulin-Like Growth Factor Receptor among Early Breast Cancer Subtypes.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0091407
- By:
- Publication type:
- Article
Prognostic Significance of ESR1 Gene Amplification, mRNA/Protein Expression and Functional Profiles in High-Risk Early Breast Cancer: A Translational Study of the Hellenic Cooperative Oncology Group (HeCOG).
- Published in:
- PLoS ONE, 2013, v. 8, n. 7, p. 1, doi. 10.1371/journal.pone.0070634
- By:
- Publication type:
- Article
Ixabepilone Administered Weekly or Every Three Weeks in HER2-Negative Metastatic Breast Cancer Patients; A Randomized Non-Comparative Phase II Trial.
- Published in:
- PLoS ONE, 2013, v. 8, n. 7, p. 1, doi. 10.1371/journal.pone.0069256
- By:
- Publication type:
- Article
Prevalence of <i>BRCA1</i> Mutations in Familial and Sporadic Greek Ovarian Cancer Cases.
- Published in:
- PLoS ONE, 2013, v. 8, n. 3, p. 1, doi. 10.1371/journal.pone.0058182
- By:
- Publication type:
- Article
Neoadjuvant and Adjuvant Immunotherapy in Resectable NSCLC.
- Published in:
- Cancers, 2024, v. 16, n. 9, p. 1619, doi. 10.3390/cancers16091619
- By:
- Publication type:
- Article
The Use of CA-125 KELIM to Identify Which Patients Can Achieve Complete Cytoreduction after Neoadjuvant Chemotherapy in High-Grade Serous Advanced Ovarian Cancer.
- Published in:
- Cancers, 2024, v. 16, n. 7, p. 1266, doi. 10.3390/cancers16071266
- By:
- Publication type:
- Article
A Multicenter, Prospective, Observational Study to Assess the Clinical Activity and Impact on Symptom Burden and Patients' Quality of Life in Patients with Advanced Soft Tissue Sarcomas Treated with Trabectedin in a Real-World Setting in Greece.
- Published in:
- Cancers, 2022, v. 14, n. 8, p. 1879, doi. 10.3390/cancers14081879
- By:
- Publication type:
- Article
Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study.
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 134, n. 1, p. 353, doi. 10.1007/s10549-012-2021-9
- By:
- Publication type:
- Article
Postoperative dose-dense sequential versus concomitant administration of epirubicin and paclitaxel in patients with node-positive breast cancer: 5-year results of the Hellenic Cooperative Oncology Group HE 10/00 phase III Trial.
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 132, n. 2, p. 609, doi. 10.1007/s10549-011-1913-4
- By:
- Publication type:
- Article
Association of osteopontin with specific prognostic factors and survival in adjuvant breast cancer trials of the Hellenic Cooperative Oncology Group.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The impact of paclitaxel and carboplatin chemotherapy on the autonomous nervous system of patients with ovarian cancer.
- Published in:
- BMC Neurology, 2016, v. 16, p. 1, doi. 10.1186/s12883-016-0710-4
- By:
- Publication type:
- Article
p85 Protein Expression is Associated with Poor Survival in HER2-Positive Patients with Advanced Breast Cancer Treated with Trastuzumab.
- Published in:
- Pathology & Oncology Research, 2015, v. 21, n. 2, p. 273, doi. 10.1007/s12253-014-9818-2
- By:
- Publication type:
- Article
Lessons from the past: Long-term safety and survival outcomes of a prematurely terminated randomized controlled trial on prophylactic vs. hemoglobin-based administration of erythropoiesis-stimulating agents in patients with chemotherapy-induced anemia.
- Published in:
- Molecular & Clinical Oncology, 2016, v. 4, n. 2, p. 211, doi. 10.3892/mco.2015.693
- By:
- Publication type:
- Article
Opposite Prognostic Impact of Single PTEN-loss and PIK3CA Mutations in Early High-risk Breast Cancer.
- Published in:
- Cancer Genomics & Proteomics (1109-6535), 2019, v. 16, n. 3, p. 195, doi. 10.21873/cgp.20125
- By:
- Publication type:
- Article
Comparison of the Ability of Different Clinical Treatment Scores to Estimate Prognosis in High-Risk Early Breast Cancer Patients: A Hellenic Cooperative Oncology Group Study.
- Published in:
- PLoS ONE, 2016, v. 11, n. 10, p. 1, doi. 10.1371/journal.pone.0164013
- By:
- Publication type:
- Article
Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study.
- Published in:
- Journal of Translational Medicine, 2015, v. 13, n. 1, p. 1, doi. 10.1186/s12967-015-0530-0
- By:
- Publication type:
- Article
Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study.
- Published in:
- 2015
- By:
- Publication type:
- journal article
The Pharmacological Profile of Cyclin-dependent Kinase (CDK) 4/6 Inhibitors: Clinical Management of Toxicity and Drug Interactions Related to CDK 4/6 Inhibitor-based Treatment in Advanced/Metastatic Breast Cancer.
- Published in:
- Forum of Clinical Oncology, 2019, v. 10, n. 2, p. 2, doi. 10.2478/fco-2019-0007
- By:
- Publication type:
- Article
The Utility of NGS Analysis in Homologous Recombination Deficiency Tracking.
- Published in:
- Diagnostics (2075-4418), 2023, v. 13, n. 18, p. 2962, doi. 10.3390/diagnostics13182962
- By:
- Publication type:
- Article
Pegfilgrastim Administered on the Same Day with Dose-Dense Adjuvant Chemotherapy for Breast Cancer Is Associated with a Higher Incidence of Febrile Neutropenia as Compared to Conventional Growth Factor Support: Matched Case-Control Study of the Hellenic Cooperative Oncology Group
- Published in:
- Oncology, 2009, v. 77, n. 2, p. 107, doi. 10.1159/000229504
- By:
- Publication type:
- Article
External Validation of the New 2023 International Federation of Gynecology and Obstetrics Staging System in Endometrial Cancer Patients: 12-Year Experience from an European Society of Gynecological Oncology-Accredited Center.
- Published in:
- Medicina (1010660X), 2024, v. 60, n. 9, p. 1421, doi. 10.3390/medicina60091421
- By:
- Publication type:
- Article
CA-125 KELIM as an Alternative Predictive Tool to Identify Which Patients Can Benefit from PARPi in High-Grade Serous Advanced Ovarian Cancer: A Retrospective Pilot Diagnostic Accuracy Study.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 10, p. 5230, doi. 10.3390/ijms25105230
- By:
- Publication type:
- Article
The Contribution of Lipidomics in Ovarian Cancer Management: A Systematic Review.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 18, p. 13961, doi. 10.3390/ijms241813961
- By:
- Publication type:
- Article
A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study.
- Published in:
- BMC Medicine, 2010, v. 8, p. 1, doi. 10.1186/1741-7015-8-3
- By:
- Publication type:
- Article
Dose-dense sequential adjuvant chemotherapy followed, as indicated, by trastuzumab for one year in patients with early breast cancer: first report at 5-year median follow-up of a Hellenic Cooperative Oncology Group randomized phase III trial.
- Published in:
- BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-515
- By:
- Publication type:
- Article
Dose-dense sequential adjuvant chemotherapy followed, as indicated, by trastuzumab for one year in patients with early breast cancer: first report at 5-year median follow-up of a Hellenic Cooperative Oncology Group randomized phase III trial
- Published in:
- BMC Cancer, 2014, v. 14, n. 1, p. 515, doi. 10.1186/1471-2407-14-515
- By:
- Publication type:
- Article
Investigating Predictive Factors of Dysphagia and Treatment Prolongation in Patients with Oral Cavity or Oropharyngeal Cancer Receiving Radiation Therapy Concurrently with Chemotherapy.
- Published in:
- Current Oncology, 2023, v. 30, n. 5, p. 5168, doi. 10.3390/curroncol30050391
- By:
- Publication type:
- Article
Dose-dense sequential adjuvant chemotherapy followed, as indicated, by trastuzumab for one year in patients with early breast cancer: first report at 5-year median follow-up of a Hellenic Cooperative Oncology Group randomized phase III trial.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Cooperative Oncology Group (HeCOG) phase III trials
- Published in:
- BMC Cancer, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2407-13-163
- By:
- Publication type:
- Article
Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Cooperative Oncology Group (HeCOG) phase III trials.
- Published in:
- 2013
- By:
- Publication type:
- journal article
XELIRI-bevacizumab versus FOLFIRI-bevacizumab as first-line treatment in patients with metastatic colorectal cancer: a Hellenic Cooperative Oncology Group phase III trial with collateral biomarker analysis.
- Published in:
- BMC Cancer, 2012, v. 12, n. 1, p. 271, doi. 10.1186/1471-2407-12-271
- By:
- Publication type:
- Article
Prognostic stratification of patients withadvanced renal cell carcinoma treated withsunitinib: comparison with the MemorialSloan-Kettering prognostic factors model.
- Published in:
- BMC Cancer, 2010, v. 10, p. 45, doi. 10.1186/1471-2407-10-45
- By:
- Publication type:
- Article